Vanguard Group’s Acrivon Therapeutics ACRV Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q2
$706K Sell
2025
Q1
$1.37M Buy
2024
Q4
$4.04M Buy
2024
Q3
$4.46M Sell
2024
Q2
$4.32M Buy
2024
Q1
$3.63M Buy
2023
Q4
$2.34M Buy
2023
Q3
$4.48M Buy
2023
Q2
$5.23M Sell
2023
Q1
$5.19M Buy